MedPath

Internet-Based Interventions for MDD

Not Applicable
Conditions
Depression
Medication Adherence
Interventions
Drug: antidepressant treatment
Other: antidepressant treatment combined with Internet-based interventions
Registration Number
NCT04684277
Lead Sponsor
Peking University
Brief Summary

The acute and remission depression patients of 18-65 years old were recruited. At the time of enrollment, the demographic, symptomatic, neuropsychological and medication adherence data was collected. After the completion of the baseline assessment and examination, the patients were given antidepressant treatment or antidepressant treatment combined with Internet-based interventions. Clinical evaluation was performed at 1, 3 months (acute patients) and 6, 12 months (remission patients) after treatment, including the medication adherence, therapeutic efficacy, recurrence rate and functional rehabilitation. Through above work, this research is expected to provide clinicians with a set of Internet generalized technologies to improve the compliance and clinical outcomes of patients with depression, and to provide patients with treatment and management of the entire disease cycle.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
440
Inclusion Criteria
  • age 18-65 years old, acute (HAMD17 > 17) and remission (HAMD17 < 8) depression
Exclusion Criteria
  • other mental illnesses, serious somatic illnesses

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
antidepressant treatmentantidepressant treatmentrecieve antidepressant treatment
antidepressant treatment combined with Internet-based interventionsantidepressant treatment combined with Internet-based interventionsrecieve antidepressant treatment combined with Internet-based interventions
Primary Outcome Measures
NameTimeMethod
recurrence rate12 months

The difference of recurrence rate between the two groups was compared

HAMD17 reduction ratio3 months

The difference of HAMD17 reduction ratio between the two groups was compared

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Yunai Su

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath